Larimar Therapeutics, Inc. (LRMR)
3.85
-0.02
(-0.52%)
USD |
NASDAQ |
Sep 03, 11:25
Larimar Therapeutics Total Liabilities (Quarterly) : 37.92M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 37.92M |
| March 31, 2026 | 50.48M |
| December 31, 2025 | 68.37M |
| September 30, 2025 | 48.31M |
| June 30, 2025 | 30.13M |
| March 31, 2025 | 25.90M |
| December 31, 2024 | 29.12M |
| September 30, 2024 | 20.62M |
| June 30, 2024 | 25.76M |
| March 31, 2024 | 17.36M |
| December 31, 2023 | 14.22M |
| September 30, 2023 | 11.24M |
| June 30, 2023 | 11.79M |
| March 31, 2023 | 12.67M |
| December 31, 2022 | 15.50M |
| September 30, 2022 | 14.35M |
| June 30, 2022 | 12.80M |
| March 31, 2022 | 14.12M |
| December 31, 2021 | 14.25M |
| September 30, 2021 | 15.87M |
| June 30, 2021 | 13.41M |
| March 31, 2021 | 14.24M |
| December 31, 2020 | 14.99M |
| September 30, 2020 | 11.32M |
| June 30, 2020 | 12.91M |
| Date | Value |
|---|---|
| March 31, 2020 | 22.96M |
| December 31, 2019 | 5.895M |
| September 30, 2019 | 33.01M |
| June 30, 2019 | 31.74M |
| March 31, 2019 | 27.82M |
| December 31, 2018 | 28.49M |
| September 30, 2018 | 28.01M |
| June 30, 2018 | 27.78M |
| March 31, 2018 | 27.62M |
| December 31, 2017 | 27.29M |
| September 30, 2017 | 7.034M |
| June 30, 2017 | 9.219M |
| March 31, 2017 | 8.597M |
| December 31, 2016 | 9.894M |
| September 30, 2016 | 12.54M |
| June 30, 2016 | 12.59M |
| March 31, 2016 | 15.60M |
| December 31, 2015 | 20.00M |
| September 30, 2015 | 17.75M |
| June 30, 2015 | 16.41M |
| March 31, 2015 | 15.05M |
| December 31, 2014 | 13.08M |
| September 30, 2014 | 18.44M |
| June 30, 2014 | 11.55M |
| March 31, 2014 | 9.945M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 7.726M |
| Marker Therapeutics, Inc. | 2.42M |
| Rezolute, Inc. | 8.625M |
| Krystal Biotech, Inc. | 141.52M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 165.30M |
| Shareholders Equity (Quarterly) | 127.38M |
| Debt to Equity Ratio | 0.0389 |
| Current Ratio | 4.703 |
| Net Debt Paydown Yield | -0.01% |